Literature DB >> 12792726

Hypoxia-inducible factor-1alpha expression and angiogenesis in gastrointestinal stromal tumor of the stomach.

Ryoji Takahashi1, Shinji Tanaka, Toru Hiyama, Masanori Ito, Yasuhiko Kitadai, Masaharu Sumii, Ken Haruma, Kazuaki Chayama.   

Abstract

Hypoxia inducible factor (HIF)-1 is reported to transactivate expression of vascular endothelial growth factor (VEGF), which is an important angiogenic factor. The aim of this study was to elucidate the clinical significance of HIF-1alpha expression in gastrointestinal stromal tumors (GIST). Specimens obtained from 53 patients who underwent surgical resection for GIST of the stomach were used in this study. Specimens were examined immunohistochemically for HIF-1alpha, VEGF, and Ki-67 expression. Tumor microvessel density (MVD) was determined immunohistochemically with anti-CD31 antibody and was estimated by averaging the counts from three high-power fields in the area showing the greatest neovascularization. HIF-1alpha expression was detected in 17 (32.1%) of 53 lesions and was correlated significantly with tumor size, liver metastasis, VEGF expression, and MVD. Prognosis was significantly poorer in patients with tumors expressing HIF-1alpha than in patients with tumors lacking HIF-1alpha expression. HIF-1alpha may play a role in angiogenesis and tumor progression of GIST through regulation of VEGF.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12792726

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  23 in total

1.  SDHB immunohistochemistry: a useful tool in the diagnosis of Carney-Stratakis and Carney triad gastrointestinal stromal tumors.

Authors:  José Gaal; Constantine A Stratakis; J Aidan Carney; Evan R Ball; Esther Korpershoek; Maya B Lodish; Isaac Levy; Paraskevi Xekouki; Francien H van Nederveen; Michael A den Bakker; Maureen O'Sullivan; Winand N M Dinjens; Ronald R de Krijger
Journal:  Mod Pathol       Date:  2010-10-01       Impact factor: 7.842

Review 2.  Molecular responses to hypoxia-inducible factor 1α and beyond.

Authors:  Jason Brocato; Yana Chervona; Max Costa
Journal:  Mol Pharmacol       Date:  2014-02-25       Impact factor: 4.436

3.  HIF-1alpha: a valid therapeutic target for tumor therapy.

Authors:  Soon-Sun Hong; Hyunseung Lee; Kyu-Won Kim
Journal:  Cancer Res Treat       Date:  2004-12-31       Impact factor: 4.679

4.  A multicenter phase II study of pazopanib in patients with advanced gastrointestinal stromal tumors (GIST) following failure of at least imatinib and sunitinib.

Authors:  K N Ganjoo; V M Villalobos; A Kamaya; G A Fisher; J E Butrynski; J A Morgan; A J Wagner; D D'Adamo; A McMillan; G D Demetri; S George
Journal:  Ann Oncol       Date:  2014-01       Impact factor: 32.976

5.  The inhibition of Endostar on the angiogenesis and growth of gastrointestinal stromal tumor xenograft.

Authors:  Tian-bao Wang; Xiu-qing Wei; Wei-hao Lin; Han-ping Shi; Wen-guang Dong
Journal:  Clin Exp Med       Date:  2011-06-10       Impact factor: 3.984

6.  Prognostic angiogenic markers (endoglin, VEGF, CD31) and tumor cell proliferation (Ki67) for gastrointestinal stromal tumors.

Authors:  Rodrigo Panno Basilio-de-Oliveira; Vera Lucia Nunes Pannain
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

7.  The clinicopathological significance of tissue levels of hypoxia-inducible factor-1alpha and vascular endothelial growth factor in gastric cancer.

Authors:  Seong-Eun Kim; Ki-Nam Shim; Sung-Ae Jung; Kwon Yoo; Joo Ho Lee
Journal:  Gut Liver       Date:  2009-06-30       Impact factor: 4.519

Review 8.  Natural product-based inhibitors of hypoxia-inducible factor-1 (HIF-1).

Authors:  Dale G Nagle; Yu-Dong Zhou
Journal:  Curr Drug Targets       Date:  2006-03       Impact factor: 3.465

9.  Serum vascular endothelial growth factor and angiogenesis are related to the prognosis of patients with gastrointestinal stromal tumors.

Authors:  T B Wang; W S Qiu; B Wei; M H Deng; H B Wei; W G Dong
Journal:  Ir J Med Sci       Date:  2009-04-15       Impact factor: 1.568

10.  HIF-1alpha determines the metastatic potential of gastric cancer cells.

Authors:  N Rohwer; S Lobitz; K Daskalow; T Jöns; M Vieth; P M Schlag; W Kemmner; B Wiedenmann; T Cramer; M Höcker
Journal:  Br J Cancer       Date:  2009-02-17       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.